08:00 , Dec 7, 2015 |  BC Week In Review  |  Clinical News

CGS-125: Clinical trial started

CapGenesis began a double-blind, placebo-controlled, Dominican Republic clinical trial to evaluate topical CGS-125 in about 48 patients with OA of both knees. CapGenesis Therapeutics LLC , Bethesda, Md.   Product: CGS-125   Business: Autoimmune  ...